CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


Athersys, Inc  (ATHX)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

ATHX's Revenue Growth by Quarter and Year

Athersys, Inc's Revenue results by quarter and year




ATHX Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - 1.53 0.31 0.40
III Quarter September - 0.40 0.60 0.22
II Quarter June 19.39 1.47 15.46 0.73
I Quarter March 1.07 0.98 10.61 0.24
FY   20.46 4.38 26.98 1.59



ATHX Revenue second quarter 2018 Y/Y Growth Comment
Athersys, Inc achieved in the second quarter, above Company average Revenue surge of 1219.12% year on year, to $ 19.39 millions.

Looking into second quarter results within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Revenue growth. While Athersys, Inc' s Revenue doubling of 1219.12% ranks overall at the positon no. 4 in the second quarter.




ATHX Revenue ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - 393.55 % -22.5 % 37.93 %
III Quarter September - -33.33 % 172.73 % -43.59 %
II Quarter June 1219.12 % -90.49 % 2017.81 % 2.82 %
I Quarter March 9.18 % -90.76 % 4320.83 % -
FY   - -83.77 % 1596.86 % -

Financial Statements
Athersys, Inc's second quarter 2018 Revenue $ 19.39 millions ATHX's Income Statement
Athersys, Inc's second quarter 2017 Revenue $ 1.47 millions Quarterly ATHX's Income Statement
New: More ATHX's historic Revenue Growth >>


ATHX Revenue (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - 282.5 % -48.33 % 81.82 %
III Quarter September - -72.79 % -96.12 % -69.86 %
II Quarter June 1712.24 % 50 % 45.71 % 204.17 %
I Quarter March -30.07 % 216.13 % 2552.5 % -17.24 %
FY (Year on Year)   - -83.77 % 1596.86 % -




Revenue second quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #3
Overall #4
Revenue Y/Y Growth Statistics
High Average Low
657.16 % 84.56 % -80.64 %
(Dec. 30, 2015)   (Mar 31 2017)

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018
You need to upgrade your Flash Player

Athersys, Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #6
Overall #13
Revenue Q/Q Growth Statistics
High Average Low
2578.03 % 284.16 % -96.26 %
(Dec 31 2015)   (Mar 31 2013)


ATHX's II. Quarter Q/Q Revenue Comment
Athersys, Inc achieved in the II. Quarter 2018 above company average sequential Revenue doubling of 1712.24%, to $ 19.39 millions, from $1.07 millions in the first quarter.
ATHX is impressively improving, with reporting better then average gain, and also accelerating speed, Aahana Banerjee , Major Pharmaceutical Preparations industry consultant said.

Within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Revenue quarter on quarter growth. While Athersys, Inc's Revenue growth quarter on quarter, overall rank is 13.


Athersys, Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
12 Months Ending
(Mar 31 2017)
Cumulative Revenue 12 Months Ending $ 22.38 $ 4.46 $ 4.38 $ 3.16 $ 3.36
Y / Y Revenue Growth (TTM) 566.39 % -74.27 % -83.76 % -88.31 % -87.41 %
Year on Year Revenue Growth Overall Ranking # 35 # 2771 # 3660 # 3566 # 37
Seqeuential Revenue Change (TTM) 401.55 % 1.89 % 38.48 % -5.84 % -80.64 %
Seq. Revenue Growth (TTM) Overall Ranking # 5 # 1580 # 168 # 3331 # 5




Cumulative Revenue growth Comment
Athersys, Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 566.39% year on year, to $ 22 millions if the fiscal year would have ended in Jun 30 2018.
Athersys, Inc's trailing twelve months Revenue growth was higher than company's average 473.03% and higher than -74.27% growth in Mar 31 2018.
But sequential rise was beneth at 401.55 % from $4.46 millions recorded in twelve months ending a quarter before Aahana Banerjee  added on.
Yet this was confirmation of strength, while the usual sequential advancement is at 84.56%.
The growth was much stronger from the previous reporting period showed at 401.55 % rise from $4.46 millions in the period from Mar 31 2018 to Mar 31 2017.

Among companies within the Healthcare sector 7 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 35, from total ranking in previous quarter at 2771.

Revenue TTM Q/Q Growth Statistics
High Average Low
657.16 %
84.56 %
-80.64 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 3
Healthcare Sector # 8
Overall # 35

Revenue TTM Y/Y Growth Statistics
High Average Low
1734.17 %
473.03 %
-88.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 3
S&P 500 # 5


You need to upgrade your Flash Player




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ATHX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ATHX's Competitors
Revenue Growth for Athersys, Inc's Suppliers
Revenue Growth for ATHX's Customers

You may also want to know
ATHX's Annual Growth Rates ATHX's Profitability Ratios ATHX's Asset Turnover Ratio ATHX's Dividend Growth
ATHX's Roe ATHX's Valuation Ratios ATHX's Financial Strength Ratios ATHX's Dividend Payout Ratio
ATHX's Roa ATHX's Inventory Turnover Ratio ATHX's Growth Rates ATHX's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Jun 30 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2018
Spark Therapeutics, Inc.  1,597.98 %$ 1,597.980 millions
Neurocrine Biosciences Inc  1,429.68 %$ 1,429.676 millions
Dynavax Technologies Corp  1,094.29 %$ 1,094.286 millions
United Cannabis Corp  1,034.34 %$ 1,034.337 millions
Macrogenics Inc  1,030.49 %$ 1,030.492 millions
Genesis Healthcare, Inc.  917.00 %$ 917.001 millions
Quest Patent Research Corp  876.64 %$ 876.639 millions
Revance Therapeutics, Inc.  814.67 %$ 814.667 millions
Enanta Pharmaceuticals Inc  662.38 %$ 662.375 millions
Tetraphase Pharmaceuticals Inc  630.08 %$ 630.076 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SMED's Profile

Stock Price

SMED's Financials

Business Description

Fundamentals

Charts & Quotes

SMED's News

Suppliers

SMED's Competitors

Customers & Markets

Economic Indicators

SMED's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071